Effects of 5,6‐Dihydroxytryptamine on the Release, Synthesis, and Storage of Serotonin: Studies Using Rat Brain Synaptosomes
- 1 February 1988
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 50 (2) , 534-542
- https://doi.org/10.1111/j.1471-4159.1988.tb02944.x
Abstract
5,6-Dihydroxytryptamine is a neurotoxic analogue of serotonin which can have profound cardiovascular effects within minutes of administration in vivo (Korner and Head. 1981). These effects have been attributed to 5,6-dihydroxytryptamine-induced serotonin release, although there has been no biochemical assessment of the extent to which this occurs. The present study utilized an in vitro synaptosomal assay to determine the short-term effects of 5,6-dihydroxytryptamine on endogenous serotonin release, synthesis, storage, and metabolism, 5,6-Dihydroxytryptamine produced a rapid depletion of serotonin. At lower concentrations of 5,6-dihydroxytryptamine (0.1-1 .mu.M), this depletion was associated primarily with an increase in the levels of 5-hydroxyindoleacetic acid, the deaminated metabolite of serotonin, with small increases in the amount of serotonin release. At higher concentrations (10-100 .mu.M), a greater proportion of the depleted serotonin was released with less metabolism occurring. When metabolism was prevented by inhibiting monoamine oxidase, the amount of serotonin which was released equaled the amount of serotonin depletion. Thus monoamine oxidase activity was important in controlling the amount of serotonin which could be released by 5,6-dihydroxytryptamine. Further studies demonstrated that an impairment in serotonin synthesis and vesicular storage could account for the rapid depletion produced by 5,6-dihydroxytryptamine. Taken together, the results indicate that 5,6-dihydroxytryptamine acts to displace serotonin from vesicular stores into the cytoplasm where it can either be deaminated by monoamine oxidase or be released. Moreover, it is hypothesized that the intraneuronal concentration of 5,6-dihydroxytryptamine is important in determining the extent of serotonin release, because it can inhibit the deamination of serotonin by monoamine oxidase.Keywords
This publication has 10 references indexed in Scilit:
- EFFECTS OF L-TRYPTOPHAN ON BLOOD-PRESSURE IN NORMOTENSIVE AND HYPERTENSIVE RATS1984
- Inhibition of human brain dihydropteridine reductase [E.C.1.6.99.10] by the oxidation products of catecholamines, the aminochromesBiochemical and Biophysical Research Communications, 1983
- HydroxylasesPublished by Springer Nature ,1983
- Cardiovascular Functions of Brain Serotonergic Neurons in the Rabbit as Analysed from the Acute and Chronic Effects of 5,6-DihydroxytryptamineJournal of Cardiovascular Pharmacology, 1982
- Central nervous control of blood pressure in relation to antihypertensive drug treamentPharmacology & Therapeutics, 1981
- Effects of noradrenergic and serotonergic neurons on blood pressure, heart rate and baroreceptor-heart rate reflex of the conscious rabbitJournal of the Autonomic Nervous System, 1981
- Chemical Lesioning of Indoleamine PathwaysPublished by Elsevier ,1977
- Effect of intracerebroventricular 5,6-dihydroxytryptamine on blood pressure of spontaneously hypertensive ratsEuropean Journal of Pharmacology, 1976
- The cardiovascular effects of intraventricular 5,6-dihydroxytryptamine in conscious hypertensive ratsClinical and Experimental Pharmacology and Physiology, 1975
- Synaptic plasma membranes from rat brain synaptosomes: Isolation and partial characterizationBiochimica et Biophysica Acta (BBA) - Biomembranes, 1971